GlassScriptPhysician profile
Dexhelyn Lim
NPI 1801413471
$1,833.01
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,767 · 2022: $66.51.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $249.91 | 2021 | |
| Abbvie INC. | $202.20 | 2021-2022 | |
| Gilead Sciences, INC. | $171.64 | 2021 | |
| Bausch Health US, LLC | $151.57 | 2021 | |
| Janssen Biotech, INC. | $147.70 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $121.97 | 2021 | |
| Emd Serono, INC. | $114.15 | 2021 | |
| Amarin Pharma, INC. | $77.48 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $74.76 | 2021 | |
| Janssen Pharmaceuticals, INC | $71.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.83 | 2021 | |
| Eisai INC. | $54.04 | 2021 | |
| Novo Nordisk INC | $51.74 | 2021 | |
| Nestle Healthcare Nutrition INC. | $48.45 | 2021 | |
| Collegium Pharmaceutical, INC. | $40.96 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.12 | 2021 | |
| Amgen INC. | $30.09 | 2021 | |
| Vanda Pharmaceuticals INC. | $24.79 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.74 | 2021 | |
| Theratechnologies INC. | $23.74 | 2021 | |
| Lilly USA, LLC | $22.59 | 2021 | |
| Adlon Therapeutics L.P. | $18.31 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.06 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dexhelyn Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.